Hester Biosciences Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Hester Biosciences Share Price

1,952.90-7.00 (-0.36%)

Closed
As On: 12 Jun, 2026, 03:44 PM IST
As On: 12 Jun, 2026, 03:40 PM IST

Sector: Agriculture/Hor...
Industry: Livestock - Pharma

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	1,980.50
High	1,990.00
Low	1,925.00
Prev Close	1,959.90
Volume	3,037
VWAP(₹)	1,957.21

Key Metrics

PE Ratio(x)	29.86
EPS - TTM(₹)	65.40
MCap(₹ Cr.)	1,661.31
MCap Rank	6
PB Ratio(x)	4.49
Div Yield(%)	0.56
Face Value(₹)	10.00
52W High(₹)	2,350.00
52W Low(₹)	1,239.30
MCap/Sales	3.23
Beta(1 Month)	0.44
BV/Share(₹)	432.34

Hester Biosc share price insights

ROE Outperforming 5 Year Average
Company delivered ROE of 15.44% in year ending Mar 31, 2026 outperforming its 5 year avg. of 11.16%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 3.29% of its operating revenues towards interest expenses and 18.84% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Hester Biosc Share Price Update
Hester Biosciences Ltd. share price moved down by -0.36% from its previous close of Rs 1,959.90. Hester Biosciences Ltd. stock last traded price is 1,952.90
Share Price Value
Today/Current/Last 1,952.901,942.15
Previous Day 1,959.901,952.15

Found Insights useful?

Hester Biosc Share Price Returns

1 Day	-0.36%
1 Month	15.22%
3 Months	36.04%
1 Year	4.92%
3 Years	19.5%
5 Years	-27.1%

Hester Biosc Share Recommendations

Recent Recos

Target₹2015
OrganizationICICI Direct
REDUCE

Target₹2835
OrganizationICICI Direct
BUY

Target₹2870
OrganizationICICI Direct
HOLD

View all Stock Recommendations

News & Analysis

View all Hester Biosc Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	97.08	78.08	80.70	86.42	74.98
Total Income Growth (%)	24.33	-3.24	-6.62	15.27	5.56
Total Expenses	68.76	64.05	63.61	65.47	66.92
Total Expenses Growth (%)	7.34	0.70	-2.85	-2.16	7.16
EBIT	28.33	14.03	17.09	20.95	8.06
EBIT Growth (%)	101.88	-17.90	-18.41	160.06	-6.11
Profit after Tax (PAT)	15.98	8.77	14.45	16.44	1.29
PAT Growth (%)	82.34	-39.34	-12.12	1,173.59	-88.93
EBIT Margin (%)	29.18	17.97	21.18	24.24	10.74
Net Profit Margin (%)	16.46	11.23	17.91	19.03	1.72
Basic EPS (₹)	19.45	10.94	16.85	20.33	1.82

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	97.89	71.39	66.05	64.44	77.73
Total Income Growth (%)	37.12	8.08	2.51	-17.10	21.21
Total Expenses	58.93	55.85	54.90	53.24	65.00
Total Expenses Growth (%)	5.51	1.73	3.11	-18.09	15.97
EBIT	38.96	15.54	11.15	11.19	12.73
EBIT Growth (%)	150.73	39.32	-0.35	-12.09	57.55
Profit after Tax (PAT)	26.38	10.67	7.21	7.84	9.64
PAT Growth (%)	147.30	48.00	-8.03	-18.65	117.05
EBIT Margin (%)	39.80	21.77	16.89	17.37	16.38
Net Profit Margin (%)	26.95	14.94	10.91	12.16	12.40
Basic EPS (₹)	31.01	12.54	8.48	9.21	11.33

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	342.28	315.03	315.18	281.24	248.75
Total Revenue Growth (%)	8.65	-0.05	12.07	13.06	13.57
Total Expenses	275.76	279.56	287.84	245.50	195.67
Total Expenses Growth (%)	-1.36	-2.88	17.25	25.47	18.16
Profit after Tax (PAT)	55.64	27.49	18.89	26.63	39.48
PAT Growth (%)	102.41	45.52	-29.06	-32.56	14.68
Operating Profit Margin (%)	23.28	15.48	15.47	16.93	24.31
Net Profit Margin (%)	16.72	8.83	6.20	10.00	16.80
Basic EPS (₹)	67.57	33.89	24.88	32.96	46.41

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	299.77	291.23	289.42	259.32	224.01
Total Revenue Growth (%)	2.93	0.63	11.60	15.77	6.61
Total Expenses	237.09	249.47	252.69	215.40	170.75
Total Expenses Growth (%)	-4.96	-1.27	17.31	26.15	13.79
Profit after Tax (PAT)	52.10	31.84	27.16	32.34	39.52
PAT Growth (%)	63.62	17.24	-16.03	-18.16	-0.96
Operating Profit Margin (%)	23.91	16.45	14.66	19.85	25.40
Net Profit Margin (%)	17.83	11.11	9.52	12.73	18.01
Basic EPS (₹)	61.24	37.43	31.93	38.02	46.45

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 3.29% of its operating revenues towards interest expenses and 18.84% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	677.94	653.39	662.35	669.97	562.16
Total Assets Growth (%)	3.76	-1.35	-1.14	19.18	36.76
Total Liabilities	310.15	326.73	359.47	381.42	294.77
Total Liabilities Growth (%)	-5.07	-9.11	-5.75	29.40	68.35
Total Equity	367.79	326.66	302.88	288.55	267.39
Total Equity Growth (%)	12.59	7.85	4.97	7.91	13.32
Current Ratio (x)	1.37	1.56	2.03	1.53	2.01
Total Debt to Equity (x)	0.52	0.66	0.82	0.96	0.86
Contingent Liabilities	0.00	117.11	143.57	145.74	170.20

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	557.35	546.00	549.55	545.82	424.44
Total Assets Growth (%)	2.08	-0.65	0.68	28.60	50.50
Total Liabilities	172.16	206.91	236.83	253.43	156.01
Total Liabilities Growth (%)	-16.79	-12.63	-6.55	62.44	251.14
Total Equity	385.18	339.09	312.71	292.38	268.43
Total Equity Growth (%)	13.59	8.44	6.95	8.92	12.99
Current Ratio (x)	2.06	1.92	2.09	1.58	2.22
Total Debt to Equity (x)	0.19	0.31	0.43	0.56	0.45
Contingent Liabilities	0.00	236.78	260.34	260.76	276.50

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	64.14	64.51	48.13	23.60	8.81
Net Cash used in Investing Activities	-3.29	-19.00	-22.65	-77.00	-116.59
Net Cash flow from Financing Activities	-48.79	-51.72	-26.05	41.76	111.61
Net Cash Flow	-2.82	-6.72	-0.41	-11.59	3.48
Closing Cash & Cash Equivalent	2.77	5.59	12.75	13.16	24.75
Closing Cash & Cash Equivalent Growth (%)	-50.47	-56.17	-3.10	-46.84	16.37
Total Debt/ CFO (x)	2.94	3.22	4.97	11.36	25.27

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	50.92	63.97	42.81	33.36	15.91
Net Cash used in Investing Activities	-2.36	-19.04	-20.63	-71.96	-110.58
Net Cash flow from Financing Activities	-48.31	-46.35	-24.07	41.38	94.96
Net Cash Flow	0.25	-1.42	-1.89	2.77	0.28
Closing Cash & Cash Equivalent	0.79	0.55	2.41	4.30	1.53
Closing Cash & Cash Equivalent Growth (%)	44.95	-77.37	-44.01	181.48	22.83
Total Debt/ CFO (x)	1.46	1.63	3.12	4.93	7.67

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 3.29 cr for investing activities which is an YoY decrease of 82.7%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	15.44	8.74	6.47	9.51	15.18
Return on Capital Employed (%)	14.74	9.12	8.46	8.64	12.28
Return on Assets (%)	8.20	4.20	2.85	3.97	7.02
Interest Coverage Ratio (x)	8.81	5.12	3.25	7.06	18.14
Asset Turnover Ratio (x)	0.50	0.47	0.46	0.43	0.53
Price to Earnings (x)	19.34	38.91	62.89	48.78	58.82
Price to Book (x)	2.98	3.39	4.05	4.62	8.88
EV/EBITDA (x)	13.11	19.69	22.03	23.66	34.11
EBITDA Margin (%)	28.96	20.88	21.11	24.71	31.37

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	13.52	9.39	8.68	11.06	14.72
Return on Capital Employed (%)	15.00	10.48	9.25	12.31	15.93
Return on Assets (%)	9.34	5.83	4.94	5.92	9.31
Interest Coverage Ratio (x)	11.17	10.38	10.13	9.27	26.43
Asset Turnover Ratio (x)	0.53	0.52	0.52	0.52	0.62
Price to Earnings (x)	20.62	33.56	43.67	40.00	58.48
Price to Book (x)	2.79	3.15	3.78	4.42	8.61
EV/EBITDA (x)	14.28	20.98	25.39	24.11	37.25
EBITDA Margin (%)	27.42	19.44	18.09	23.70	29.73

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 15.44% in year ending Mar 31, 2026 outperforming its 5 year avg. of 11.16%. (Source: Consolidated Financials)

Found Financials useful?

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Hester Biosc	29.86	4.52	15.44	14.74	8.20	6.70	23.28	15.36	67.57	1.37	0.52	2.94
Add More stocks of your interest to compare.

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance
- CHART
- TABLE
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
- Choose from Peers
  Choose from Stocks
- There’s no suggested peer for this stock.
NAME 1D 1W 1M 3M 1Y 3Y 5Y
Hester Biosc Stock Performance -0.36 12.22 30.03 24.21 10.96 12.25 -30.11
Add More stocks of your interest to compare.
All values in %
Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 45,70,944 53.73 % 0.00
Pledge 0 0.00 % 0.00
FII 32,134 0.38 % -0.14
DII 165 0.00 % 0.00
MF 165 0.00 % 0.00
Others 39,03,622 45.89 % 0.14
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 53.73 53.73 53.73 53.73
Pledge 0.00 0.00 0.00 0.00
FII 0.38 0.52 0.53 0.51
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 45.89 45.75 45.74 45.76

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.02
  Amount Invested (in Cr.)
- 0.04468414%
  % of AUM
- -3.39
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.04%
  % of AUM
- 4.26
  % Change (MoM basis)

View all Mutual Fund Schemes

Hester Biosc Top Searches

Corporate Actions

Recent
Final
110%
May 15, 2026
Board Meeting
Audited Results & Final Dividend
May 08, 2026
General Meeting
-
Feb 04, 2026

Announced on	Meeting on
May 08, 2026	May 15, 2026
Audited Results & Final Dividend
Jan 21, 2026	Jan 30, 2026
Quarterly Results
Nov 04, 2025	Nov 12, 2025
Quarterly Results
Jul 23, 2025	Aug 01, 2025
Quarterly Results
May 02, 2025	May 09, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 09, 2025 Aug 06, 2025 70%
May 10, 2024 Aug 22, 2024 60%
May 17, 2023 Sep 13, 2023 80%
May 20, 2022 Aug 11, 2022 100%
May 15, 2026 - 110%
Bonus
Announced on Ex-Date
Aug 14, 2012 Sep 27, 2012
Bonus Ratio: 1 share(s) for every 2 shares held
Splits
No Data Available
Rights
Announced on Ex-Date
Nov 15, 2005 May 29, 2006
Rights ratio: 2 share for every 5 held at a price of Rs 70.0

AGM/EGM Meetings

Announced on	Meeting on
Feb 04, 2026	Mar 11, 2026
-
Jul 11, 2025	Aug 13, 2025
-
Jan 13, 2025	Feb 15, 2025
-
Jul 26, 2024	Aug 29, 2024
Book closure from Aug 23, 2024 to Aug 29, 2024
Aug 23, 2023	Sep 20, 2023
Rs.8.0000 per share(80%)Final Dividend & A.G.M.

About Hester Biosc

Hester Biosciences Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 1,661.31 Crore) operating in Agriculture/Horticulture/Livestock sector.

Hester Biosciences Ltd. key Products/Revenue Segments include Poultry & Poultry Farming, Export Incentives for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 97.08 Crore, up 24.33 % from last quarter Total Income of Rs 78.08 Crore and up 29.49 % from last year same quarter Total Income of Rs 74.97 Crore. Company has reported net profit after tax of Rs 14.69 Crore in latest quarter.

The company’s top management includes Dr.Bhupendra Gandhi, Mr.Rajiv Gandhi, Ms.Priya Gandhi, Mr.Ameet Desai, Mr.Anil Jain, Mr.Ashok Bhadakal, Mr.Jatin Trivedi, Ms.Sandhya Patel, Mr.Ravin Gandhi, Mr.Sanjiv Gandhi, Ms.Nina Gandhi, Mr.Divyesh Maru, Mr.Vinod Mali. Company has Shah Karia & Associates as its auditors. As on 31-03-2026, the company has a total of .85 Crore shares outstanding.

Hester Biosc Share Price Today is Rs. 1952.90. On previous day, the Hester Biosc Share Price (NSE) closed at Rs. 1959.9, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 53.73% of the stake in Hester Biosc shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Hester Biosc stocks was 0.38% as compared to 0.52% in Dec 2025 with decrease of 0.14%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Hester Biosc shares 0.0% was held by mutual funds. The rest including public held is 45.89%. Hester Biosc stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Hester Biosc Dividend: Ever since 1987, Hester Biosc dividends has been paid out around 27 times. As on 12 Jun, 2026, 03:44 PM IST, The overall dividend yield for Hester Biosc stands at 0.56%. The last dividend paid was on August 6, 2025 (Rs. 7.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 65.4.

Hester Biosc Bonus: The most recent bonus issue had been in year September 27, 2012 around 13 years ago at 2 : 1 ratio. The first bonus issue was announced in Aug 2012.

Stock Forecast:
After showing 97.08 Cr. of sales and 24.33% of quarterly net profit, there have been multiple ups and downs in the Hester Biosc stock prices in the past few weeks. For example, Hester Biosc stock price on 5th of June 2026 was around Rs. 1961.6. Hester Biosc share price now stands at an average of Rs. 1952.90. Judging by last week's performance, stock is in down trend.

Hester Biosc has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Hester Biosc share.

Historical Prices and Performance:
Hester Biosc, incorporated in 1987 is a Small Cap company (with a market cap of Rs. 1661.31) operating in Agriculture/Horticulture/Livestock sector.
The Return of Equity (ROE) in last five financial years given by Hester Biosc stock was 15.44%, 8.74%, 6.47%, 9.51% and 15.18% respectively.
The Hester Biosc share gave a 3 year return of 19.5% as compared to Nifty 50 which gave a return of 26.99%.
Hester Biosc announced 70.0% final dividend on August 6, 2025.

Key Metrics:
PE Ratio of Hester Biosc is 29.97
Prices/Sales Ratio of Hester Biosc is 3.23
Price/Book Ratio of Hester Biosc is 4.53

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 29.97 and 4.53 respectively.

Leadership of Hester Biosc :
Vinod Mali is Co. Secretary & Compl. Officer
Divyesh Maru is Chief Financial Officer
Bhupendra Gandhi is Chairman
Rajiv Gandhi is Managing Director & CEO
Priya Gandhi is Executive Director
Ravin Gandhi is Director
Sanjiv Gandhi is Director
Ashok Bhadakal is Independent Director
Sandhya Patel is Independent Director
Ameet Desai is Independent Director
Anil Jain is Independent Director
Jatin Trivedi is Independent Director
Nina Gandhi is Alternate Director

Show More

Industry

Livestock - Pharma

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap

Address

�Pushpak� 1st Floor,Panchvati Circle,Motilal Hirabhai Road,Ahmedabad, Gujarat - 380006

Contact

http://www.hester.in

Executive Leadership

BG

Bhupendra Gandhi

Chairman

RG

Rajiv Gandhi

Managing Director & CEO

PG

Priya Gandhi

Executive Director

AD

Ameet Desai

Independent Director

Show More

Auditors

Chandulal M Shah & Co.

Shah Karia & Associates

FAQs about Hester Biosc share

1. What's Hester Biosc share price today and what are Hester Biosc share returns ?
Hester Biosc share price is Rs 1,952.90 as on 12 Jun, 2026, 03:44 PM IST. Hester Biosc share price is down by 0.36% based on previous share price of Rs 1,939.2. Hester Biosc share price trend:
- Last 12 Months: Hester Biosc share price moved up 4.92%
- Last 3 Years: Hester Biosc Share price moved up by 19.50%
2. What is the market cap of Hester Biosc?
Hester Biosc share has a market capitalization of Rs 1,661.31 Cr. Within Agriculture/Horticulture/Livestock sector, it's market cap rank is 6.
3. What is 52 week high/low of Hester Biosc share price?
52 Week high of Hester Biosc share is Rs 2,350.00 while 52 week low is Rs 1,239.30
4. What are the returns for Hester Biosc share?
Return Performance of Hester Biosc Shares:
- 1 Week: Hester Biosc share price moved down by 0.44%
5. What is the PE & PB ratio of Hester Biosc?
The PE ratio of Hester Biosc stands at 29.97, while the PB ratio is 4.53.

Top Gainers

As on 04:06 PM | 12 Jun 2026

84.57

14.09 (20.00%)

Authum Investment

530.15

70.20 (15.27%)

Tata Teleservices

46.44

4.29 (10.18%)

152.45

13.87 (10.01%)

Netweb Technologies

4,587.40

396.00 (9.45%)

Top Losers

As on 03:58 PM | 12 Jun 2026

1,375.70

-46.80 (-3.29%)

417.80

-11.56 (-2.70%)

246.20

-6.41 (-2.54%)

1,429.20

-35.90 (-2.46%)

OneSource Specialty

1,612.50

-38.91 (-2.36%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.